Insider Purchases: Inside the Buy

Tag: CooperSurgical

CooperCompanies COO stock analysis showing $1.33M insider buying near $53, record $273M free cash flow and a $3B buyback plan.

👁️ CooperCompanies (COO): Insiders Buy $1.33M at $53–$54 as the Stock Crashes

Three CooperCompanies directors just put $1.33 million of their own money into COO near $53–$54. Add record $273M free cash flow, an expanded $3B buyback authorization and an 11.1× forward P/E—and this beaten-down medtech stock deserves a much closer look. 👁️

 

Read entire article

Tags: buy or sell COO, CarpeDiem, contact lenses, COO, COO stock, CooperCompanies, CooperCompanies stock, CooperSurgical, CooperVision, featured-insiders, featured-value, fertility stocks, free cash flow, FUNanc1al, FunStock Index, healthcare stocks, hub-insiders, hub-value, insider buying, insider purchases, insider trading, InsiderBuying, medical device stocks, MedTech, medtech stocks, PEG ratio, risks buying COO, share repurchases, ShareBuyback, stock buybacks, undervalued stocks, value stocks, ValueInvesting, why buy COO
Executives of CooperCompanies buying shares represented as oversized contact lenses, symbolizing insider confidence in COO stock.

CEO, CFO, COO, and President, CooperVision, Are All Buying Shares of The Cooper Companies. Should You?

The CEO, CFO, COO, and President of CooperCompanies all just bought shares. Insiders, institutions, and even the company itself are betting on the stock. Value play or just another lens cleaner? 👓💸

Read entire article

Tags: CEO Buys, CEO Conviction, CEO insider buying, CEO Stock Purchase, CEOBuyIn, CEOConfidence, CFO Insider Buying, CFOBuyIn, contrarian investing, Contrarian Investments, Contrarian Picks, Contrarian Plays, Contrarian Stocks, COO Insider Buying, COO stock, CooperCompanies, CooperSurgical, CooperVision, Funanc1al, Funanc1al Edge, FUNanc1al Humor, FUNanc1al Investing, Insider Buying, Institutional Investors, Medical Devices, Stocks to Watch, Value Stocks